RAD51 and neoplasm: This test can be considered a read out of a functional test of HR repair and differs from what was reported on the RAD51 foci induction after treatment with DNA damaging agents; it evaluates the number of RAD51 foci in tumor-proliferating cells (geminin-positive cells) control, untreated condition (basal condition, i.e., tumor at diagnosis).